Name
bloods_vldlcholcal
Label
Very low-density lipoproteins (VLDL) cholesterol
Units
milligrams per deciliter (mg/dL)
Type
numeric
Visit number vs Very low-density lipoproteins (VLDL) cholesterol
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Baseline Visit | 166 | 24.4 | ± 11.6 | 22.0 | 8.0 | 77.0 | 3 | 169 |
| Month-6 Follow-up Visit | 133 | 23.4 | ± 10.1 | 20.0 | 9.0 | 56.0 | 36 | 169 |
| Month-12 Follow-up Visit | 78 | 25.6 | ± 12.1 | 22.5 | 12.0 | 65.0 | 30 | 108 |
Treatment arm vs Very low-density lipoproteins (VLDL) cholesterol
Baseline Visit
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 166 | 24.4 | ± 11.6 | 22.0 | 8.0 | 77.0 | 3 | 169 |
| Conservative Medical Therapy (CMT) | 43 | 24.1 | ± 11.1 | 20.0 | 11.0 | 59.0 | 1 | 44 |
| CMT + Sham CPAP | 42 | 25.1 | ± 12.3 | 22.5 | 11.0 | 77.0 | - | 42 |
| CMT + Active CPAP | 41 | 21.6 | ± 11.6 | 18.0 | 8.0 | 63.0 | 1 | 42 |
| CMT + Active CPAP + Motivational Enhancement | 40 | 26.9 | ± 11.1 | 27.0 | 9.0 | 59.0 | 1 | 41 |
Treatment arm vs Very low-density lipoproteins (VLDL) cholesterol
Month-6 Follow-up Visit
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 133 | 23.4 | ± 10.1 | 20.0 | 9.0 | 56.0 | 36 | 169 |
| Conservative Medical Therapy (CMT) | 34 | 23.6 | ± 10.1 | 21.0 | 11.0 | 47.0 | 10 | 44 |
| CMT + Sham CPAP | 34 | 22.9 | ± 10.2 | 19.5 | 11.0 | 56.0 | 8 | 42 |
| CMT + Active CPAP | 34 | 22.8 | ± 10.8 | 19.0 | 9.0 | 46.0 | 8 | 42 |
| CMT + Active CPAP + Motivational Enhancement | 31 | 24.2 | ± 9.7 | 24.0 | 11.0 | 50.0 | 10 | 41 |
Treatment arm vs Very low-density lipoproteins (VLDL) cholesterol
Month-12 Follow-up Visit
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 78 | 25.6 | ± 12.1 | 22.5 | 12.0 | 65.0 | 30 | 108 |
| Conservative Medical Therapy (CMT) | 22 | 27.0 | ± 14.9 | 22.0 | 12.0 | 65.0 | 7 | 29 |
| CMT + Sham CPAP | 21 | 23.3 | ± 11.0 | 19.0 | 12.0 | 46.0 | 6 | 27 |
| CMT + Active CPAP | 17 | 23.4 | ± 11.4 | 19.0 | 12.0 | 57.0 | 9 | 26 |
| CMT + Active CPAP + Motivational Enhancement | 18 | 28.6 | ± 10.0 | 28.5 | 13.0 | 46.0 | 8 | 26 |
Age at visit vs Very low-density lipoproteins (VLDL) cholesterol
Baseline Visit
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 166 | 24.4 | ± 11.6 | 22.0 | 8.0 | 77.0 | 3 | 169 |
| 46.0 to 59.0 years | 40 | 28.9 | ± 15.6 | 25.5 | 8.0 | 77.0 | 3 | 43 |
| 59.0 to 66.0 years | 42 | 24.2 | ± 8.9 | 23.0 | 9.0 | 42.0 | - | 42 |
| 66.0 to 69.0 years | 42 | 21.9 | ± 9.5 | 19.5 | 10.0 | 47.0 | - | 42 |
| 70.0 to 76.0 years | 42 | 22.9 | ± 10.6 | 18.5 | 9.0 | 54.0 | - | 42 |
Age at visit vs Very low-density lipoproteins (VLDL) cholesterol
Month-6 Follow-up Visit
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 133 | 23.4 | ± 10.1 | 20.0 | 9.0 | 56.0 | 36 | 169 |
| 46.0 to 60.0 years | 26 | 26.7 | ± 12.0 | 25.0 | 11.0 | 56.0 | 17 | 43 |
| 60.0 to 66.0 years | 34 | 22.6 | ± 9.1 | 21.0 | 9.0 | 42.0 | 8 | 42 |
| 66.0 to 70.0 years | 39 | 22.7 | ± 8.8 | 19.0 | 11.0 | 47.0 | 3 | 42 |
| 70.0 to 77.0 years | 34 | 22.2 | ± 10.8 | 19.0 | 10.0 | 50.0 | 8 | 42 |
Age at visit vs Very low-density lipoproteins (VLDL) cholesterol
Month-12 Follow-up Visit
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 78 | 25.6 | ± 12.1 | 22.5 | 12.0 | 65.0 | 30 | 108 |
| 47.0 to 60.0 years | 14 | 30.1 | ± 12.0 | 26.0 | 16.0 | 61.0 | 13 | 27 |
| 60.0 to 66.0 years | 21 | 28.5 | ± 15.6 | 22.0 | 12.0 | 65.0 | 6 | 27 |
| 66.0 to 70.0 years | 21 | 24.0 | ± 9.4 | 21.0 | 12.0 | 45.0 | 6 | 27 |
| 71.0 to 77.0 years | 22 | 21.4 | ± 9.5 | 16.0 | 12.0 | 46.0 | 5 | 27 |
Gender vs Very low-density lipoproteins (VLDL) cholesterol
Baseline Visit
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 166 | 24.4 | ± 11.6 | 22.0 | 8.0 | 77.0 | 3 | 169 |
| Male | 108 | 24.0 | ± 11.7 | 22.5 | 8.0 | 77.0 | 2 | 110 |
| Female | 58 | 25.1 | ± 11.4 | 20.5 | 9.0 | 59.0 | 1 | 59 |
Gender vs Very low-density lipoproteins (VLDL) cholesterol
Month-6 Follow-up Visit
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 133 | 23.4 | ± 10.1 | 20.0 | 9.0 | 56.0 | 36 | 169 |
| Male | 92 | 22.5 | ± 9.3 | 19.0 | 9.0 | 56.0 | 18 | 110 |
| Female | 41 | 25.4 | ± 11.5 | 23.0 | 11.0 | 50.0 | 18 | 59 |
Gender vs Very low-density lipoproteins (VLDL) cholesterol
Month-12 Follow-up Visit
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 78 | 25.6 | ± 12.1 | 22.5 | 12.0 | 65.0 | 30 | 108 |
| Male | 52 | 25.6 | ± 12.4 | 23.0 | 12.0 | 65.0 | 20 | 72 |
| Female | 26 | 25.4 | ± 11.8 | 21.5 | 12.0 | 57.0 | 10 | 36 |
Race vs Very low-density lipoproteins (VLDL) cholesterol
Baseline Visit
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 165 | 24.4 | ± 11.6 | 22.0 | 8.0 | 77.0 | 3 | 168 |
| White | 149 | 24.5 | ± 11.8 | 22.0 | 9.0 | 77.0 | 3 | 152 |
| American Indian or Alaskan Native | - | - | - | - | - | - | - | - |
| Black or African American | 11 | 22.2 | ± 10.2 | 19.0 | 8.0 | 38.0 | - | 11 |
| Asian | 4 | 27.8 | ± 10.3 | 25.5 | 18.0 | 42.0 | - | 4 |
| Native Hawaiian or other Pacific islander | - | - | - | - | - | - | - | - |
| Other | 1 | 28.0 | - | 28.0 | 28.0 | 28.0 | - | 1 |
| Multiple | - | - | - | - | - | - | - | - |
Race vs Very low-density lipoproteins (VLDL) cholesterol
Month-6 Follow-up Visit
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 132 | 23.4 | ± 10.1 | 20.0 | 9.0 | 56.0 | 36 | 168 |
| White | 123 | 23.4 | ± 10.0 | 20.0 | 9.0 | 56.0 | 29 | 152 |
| American Indian or Alaskan Native | - | - | - | - | - | - | - | - |
| Black or African American | 6 | 23.5 | ± 14.5 | 17.0 | 11.0 | 42.0 | 5 | 11 |
| Asian | 3 | 26.0 | ± 9.2 | 24.0 | 18.0 | 36.0 | 1 | 4 |
| Native Hawaiian or other Pacific islander | - | - | - | - | - | - | - | - |
| Other | - | - | - | - | - | - | 1 | 1 |
| Multiple | - | - | - | - | - | - | - | - |
Race vs Very low-density lipoproteins (VLDL) cholesterol
Month-12 Follow-up Visit
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 78 | 25.6 | ± 12.1 | 22.5 | 12.0 | 65.0 | 30 | 108 |
| White | 71 | 25.3 | ± 12.1 | 22.0 | 12.0 | 65.0 | 24 | 95 |
| American Indian or Alaskan Native | - | - | - | - | - | - | - | - |
| Black or African American | 5 | 27.6 | ± 13.6 | 25.0 | 14.0 | 45.0 | 4 | 9 |
| Asian | 2 | 30.5 | ± 14.8 | 30.5 | 20.0 | 41.0 | 1 | 3 |
| Native Hawaiian or other Pacific islander | - | - | - | - | - | - | - | - |
| Other | - | - | - | - | - | - | 1 | 1 |
| Multiple | - | - | - | - | - | - | - | - |